Exact Sciences schedules first quarter 2021 earnings call

Rhea-AI Summary

Exact Sciences Corp. (Nasdaq: EXAS) will release its first quarter 2021 financial results on May 4, 2021, after the U.S. markets close. Following this, a webcast and conference call will be held at 5 p.m. EDT to discuss the results and business developments. The company focuses on cancer screening and diagnostics, leveraging successful products like Cologuard and Oncotype DX. Exact Sciences aims to enhance patient care through innovative solutions and continued investment in its product pipeline.

Positive

• Company is scheduled to discuss first quarter 2021 financial results, indicating ongoing transparency with investors.
• Continued investment in product pipeline suggests potential for future growth in cancer diagnostics.

Negative

• No specific financial metrics or guidance were provided, leaving investors without clear expectations.

MADISON, Wis., April 8, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its first quarter 2021 financial results after the close of the U.S. financial markets on May 4, 2021. Following the release, company management will host a webcast and conference call at 5 p.m. EDT to discuss financial results and business progress.

First quarter 2021 webcast & conference call details
Date:	Tuesday, May 4, 2021
Time:	5 p.m. EDT
Webcast:	The live webcast can be accessed at www.exactsciences.com
Telephone:	Domestic callers, dial 833-235-7650
	International callers, dial +1 647-689-4171
	Access code for both domestic and international callers: 5789488

An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-585-8367 domestically or 416-621-4642 internationally. The access code for the replay of the call is 5789488. The webcast, conference call and replay are open to all interested parties.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com 
608-535-8815

View original content to download multimedia:http://www.prnewswire.com/news-releases/exact-sciences-schedules-first-quarter-2021-earnings-call-301264655.html

SOURCE EXACT SCIENCES CORP

FAQ

When will Exact Sciences release its first quarter 2021 earnings report?

Exact Sciences will release its first quarter 2021 financial results on May 4, 2021.

What time is the Exact Sciences conference call for Q1 2021 results?

The conference call will take place at 5 p.m. EDT on May 4, 2021.

How can I access the Exact Sciences earnings call?

The earnings call can be accessed via the Exact Sciences website.

What are the key products of Exact Sciences?

Exact Sciences is known for its cancer screening products Cologuard and Oncotype DX.